CAGW and coalition partners share the FDA’s deep commitment to the development of a robust biosimilars market and appreciate the Agency’s work to develop an efficient approval pathway for biosimilars to bring savings and access to America’s patients.
CCAGW joins coalition to support H.R. 856, the Physician Pro Bono Care Act.
CAGW encourages the administration to continues its efforts to retain America’s leadership role in researching and developing 5G network technologies and future wireless generations.
CCAGW urges representatives to oppose H.R. 535, the PFAS Action Act, which would require the EPA to designate all PFAS as hazardous materials within one year of enactment of the legislation, place all PFAS under the Superfund law, and put a five-…
CAGW asks the FAA to implement enhanced ADS-C systems as a cost-effective, failsafe means to comply with scheduled changes to minimum separation standards in U.S. oceanic airspace.
CCAGW urges representatives to support USMCA ratification.
CCAGW urges Senators to oppose any price control, or similar mandate, that may be offered as an amendment to any end-of-the-year continuing resolution or omnibus appropriations bill.
CCAGW joins coalition urging Members of Congress to avoid forcing any surprise billing proposal into year-end legislation.
CCAGW urges Congress to reject any attempt to modify H.R. 5035, the Television Viewer Protection Act of 2019, with provisions contained in or similar to H.R. 5140.
We urge the Trump administration to strike while the iron is hot by stating prior to the December 10 deadline that the goal of the United States is not to kill the Appellate Body, but rather to reform it.
